Dr. Kjell Öberg is professor of endocrine oncology at the Medical Faculty of Uppsala University. He is the head of the Endocrine Oncology Clinic and a specialist in endocrinology and internal medicine. He founded the Dept. of Endocrine Oncology at Uppsala University Hospital and has more than 20 years experience in the field of neuroendocrine tumors. Between 1986 and 1992 he was clinical associate director of the Ludwig Institute for Cancer Research. From 1998 to 2002 he was chairman of the Department of Medical Sciences at the Medical Faculty of Uppsala University. He is currently Dean of the Medical Faculty since July 2002.

Dr. Öberg was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) 1995-2000 and is chairman of the Nordic Endocrine Tumor Network. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogues and developed assays for tumor markers such as Chromogranin A and radiological procedures such as specialized PET scannings.

He described for the first time (1988) a genetic deletion in multiple endocrine neoplasia Type 1 (MEN1). In 1991 Dr. Öberg received the European Interferon Research reward. He has given more than hundreds of lections at international meetings and he has published more than 400 papers within his research field. He is author of chapters of carcinoid tumors in several international textbooks (William’s Textbook of Endocrinology, Leslie de Groot Textbook of Endocrinology, Clinical Endocrinology and so forth).

In June 2003 Dr. Öberg received the award “Eminent Scientist Year 2003” by the International Research Promotion Council (IRPC) and World Scientist Forum.

In November 2004 he received the European Gold Medal in Endocrinology from the English Endocrine Society